The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, ...

The US Food and Drug Administration's committee of independent vaccine experts gathered Thursday to discuss the future of ...

The FDA says COVID variants continue to evolve, and vaccines’ immunity can wane over time, presenting a continued need for ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

Currently, Pfizer's and Moderna's omicron shots are authorized as a booster, while the first two doses are still the old shots based on the original strain.

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency ...

One of many safety monitoring systems found a potential link between Pfizer's new booster and stroke risk in older adults, ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

bivalent shot and both the CDC and FDA continue to recommend that everyone aged 6 months and older stay up-to-date with their COVID-19 vaccination. Reporting by Bhanvi Satija in Bengaluru ...